Cell-Permeable Peptide Inhibitors of JNK

Christophe Bonny(University Hospital of Lausanne), Daniel F. Schorderet(Institut de Recherche en Opthalmologie)

Diabetes

January 1, 2001

10.2337/diabetes.50.1.77

Cited by 570

Related Papers

Aberrant accumulation of EFEMP1 underlies drusen formation in Malattia Leventinese and age-related macular degeneration

|Proceedings of the National Academy of Sciences|2002|232

MAP kinase pathways in UV-induced apoptosis of retinal pigment epithelium ARPE19 cells

|APOPTOSIS|2008|110

JNK3 is abundant in insulin-secreting cells and protects against cytokine-induced apoptosis

|Diabetologia|2009|47

Retinal ischemia-induced apoptosis is associated with alteration in Bax and Bcl-x(L) expression rather than modifications in Bak and Bcl-2.

|PubMed|2009|30

JNK3 Maintains Expression of the Insulin Receptor Substrate 2 (IRS2) in Insulin-Secreting Cells: Functional Consequences for Insulin Signaling

|PLoS ONE|2012|28